4//SEC Filing
MACK DAVID J. 4
Accession 0001104659-26-002973
CIK 0001720893other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 7:00 PM ET
Size
5.7 KB
Accession
0001104659-26-002973
Insider Transaction Report
Form 4
MACK DAVID J.
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-01-09+17,000→ 17,000 totalExercise: $2.01Exp: 2036-01-09→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date.
Signature
/s/ Richard Steinhart, Attorney-in-Fact for David J. Mack|2026-01-12
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001694466
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 7:00 PM ET
- Size
- 5.7 KB